Referências

  1. ALI, R. et al. Icterus neonatorum in near-term and term infants: an overview. Sultan Qaboos University Medical Journal, Sultan Qaboos, v. 12, n. 2, p. 153-160, 2012. DOI: 10.12816/0003107.
  2. BERK, P. D. et al. Unconjugated hyperbilirubinemia. Physiologic evaluation and experimental approaches to therapy. Annals of Internal Medicine, Philadelphia, v. 82, n. 4, p. 552-570, 1975. DOI: 10.7326/0003-4819-82-4-552.
  3. RUBALTELLI, F. F.; GRIFFITH, P. F. Management of neonatal hyperbilirubinaemia and prevention of kernicterus. Drugs, New York, v. 43, n. 6, p. 864-872, 1992. DOI: 10.2165/00003495-199243060-00006.
  4. SCHWARTZ, H. P. et al. Hyperbilirubinemia: current guidelines and emerging therapies. Pediatric Emergency Care, Philadelphia, v. 27, n. 9, p. 884-889, 2011. DOI: 10.1097/PEC.0b013e31822c9b4c.
  5. PAVLOVIC MARKOVIC, A. et al. Jaundice as a diagnostic and therapeutic problem: a general practitioner’s approach. Digestive Diseases, Basel, v. 40, n. 3, p. 362-369, 2022. DOI: 10.1159/000517301.
  6. ZAHEAD PASHA, Y. et al. Etiology and therapeutic management of neonatal jaundice in Iran: a systematic review and meta-analysis. World Journal of Pediatrics: WJP, Beijing, v. 16, n. 5, p. 480-493, 2020. DOI: 10.1007/s12519-020-00339-3.
  7. NAEEM, H. et al. The need for neonatal jaundice screening awareness in the Pakistani population: short communication. Annals of Medicine and Surgery (2012), London, v. 85, n. 8, p. 4187-4189, 2023. DOI: 10.1097/MS9.0000000000000960.
  8. COSTA, I. S. et al. Rare cause of jaundice in a term newborn. BMJ Case Reports, London, v. 17, n. 2, p. e258661, 2024. DOI: 10.1136/bcr-2023-258661.
  9. WATCHKO, J. F.; MAISELS, M. J. Jaundice in low birthweight infants: pathobiology and outcome. Archives of Disease in Childhood. Fetal and Neonatal Edition, London, v. 88, n. 6, p. F455-F458, 2003. DOI: 10.1136/fn.88.6.f455.
  10. SOCIEDADE BRASILEIRA DE PEDIATRIA. Hiperbilirrubinemia indireta no período neonatal. Disponível em: <https://www.sbp.com.br/fileadmin/user_upload/23176c-MO_Hiperbilirrubinemia_indireta_periodo_neo.pdf>. Acesso em: 8 ago. 2024.